The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035
NIDDK lists orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) for long-term use, along with setmelanotide (Imcivree) for certain rare genetic causes of obesity
These compounds have been shown to support metabolic health by stimulating GLP-1 secretion
It works well for all skin types, including oily skin, and layers smoothly under sunscreen and moisturizer
Novo Nordisk also has a Wegovy coupon that offers significant savings on the cost of Wegovy, even if your UHC plan doesnt cover it
That said, dedicated studies examining CJC-1295 specifically for injury healing are limited